The full article is available here as HTML.
Press Ctrl-C to copy
[CAPE TOWN] An industry-led ‘patent pool’, set up last year to target neglected diseases, has finally yielded some fruit.
Drug company GlaxoSmithKline (GSK) launched the pool last year, saying the company would make patents for some of its drugs and manufacturing processes freely available and with no-cost licences. Many hoped the move would boost research into neglected diseases.
Yet there was little initial response to the pool